Vilin Bio Med accepts resignation of CFO Avula Hariprasad

1 min read     Updated on 12 Jun 2026, 09:49 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Vilin Bio Med accepted the resignation of Avula Hariprasad as Chief Financial Officer effective June 11, 2026. Hariprasad stepped down due to pre-occupation and other engagements. The company disclosed the change pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
42783573

*this image is generated using AI for illustrative purposes only.

Vilin Bio Med has accepted the resignation of Avula Hariprasad from the position of Chief Financial Officer, effective June 11, 2026. Hariprasad stepped down due to pre-occupation and other commitments requiring his attention. The resignation was tendered with effect from the close of business hours on June 11, 2026.

The disclosure was made to the National Stock Exchange of India in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that there are no other material reasons for the resignation beyond those stated.

Key Management Change Details

The following table outlines the specifics of the managerial change:

Particulars Details
Name of the Director / KMP Mr. Avula Hariprasad
Reason for Change Resignation as the Chief Financial Officer of the Company with effect from closing of the business hours of June 11, 2026
Date of Cessation June 11, 2026
Brief Profile Not Applicable

The resignation letter was submitted to the Board of Directors of Vilin Bio Med Limited. Hariprasad expressed gratitude to the Board and management for the support during his tenure and wished the company continued success.

Historical Stock Returns for Vilin Bio Med

1 Day5 Days1 Month6 Months1 Year5 Years
-1.57%-3.39%-9.35%+136.18%+71.85%+64.91%

Who will be appointed as the new CFO, and what is the timeline for the announcement?

How will the CFO transition impact Vilin Bio Med's financial strategy and upcoming reporting deadlines?

What are the potential market reactions to this sudden leadership change?

Vilin Bio Med reclassifies outgoing promoter to public

1 min read     Updated on 19 May 2026, 08:44 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Vilin Bio Med Limited reclassified outgoing promoter Mr. Devireddy Srinivas Reddy to the public category after an open offer concluded on September 15, 2025. Reddy holds 4,45,425 equity shares, representing 3.19% of the total voting capital. The move complies with SEBI LODR Regulation 31A(10).

powered bylight_fuzz_icon
40749262

*this image is generated using AI for illustrative purposes only.

Vilin Bio Med Limited has completed the reclassification of its outgoing promoter to the public category. This action follows the successful conclusion of an open offer for the acquisition of 26% of the voting share capital, which finalized on September 15, 2025. The management and control of the company have subsequently been transferred to the new acquirer(s), who have been classified as the new promoter(s).

The reclassification utilizes the exemption provided under Regulation 31A(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Mr. Devireddy Srinivas Reddy, the outgoing promoter, satisfies all necessary conditions specified in the regulation for this change in status.

Details of Reclassification

The outgoing promoter has ceased to exercise control over the affairs of the company and does not hold any special rights. The certification confirms compliance with specific regulatory requirements regarding shareholding and governance.

Name of the Outgoing Promoter Number of Equity Shares Held % of Total Voting Capital
Mr. Devireddy Srinivas Reddy 4,45,425 3.19

Regulatory Compliance

The company certified that the outgoing promoter does not hold more than 10% of the total voting rights and is not represented on the Board of Directors. Additionally, the individual shall not act as a Key Managerial Person for a period of three years from the date of reclassification. The confirmation also states that the promoter is not a wilful defaulter or a fugitive economic offender as per relevant guidelines.

Historical Stock Returns for Vilin Bio Med

1 Day5 Days1 Month6 Months1 Year5 Years
-1.57%-3.39%-9.35%+136.18%+71.85%+64.91%

How might the new acquirer(s) restructure Vilin Bio Med Limited's business strategy and operations following the completion of management control transfer?

What are the potential implications for Vilin Bio Med Limited's stock performance and investor sentiment now that the ownership transition is fully formalized?

Could Mr. Devireddy Srinivas Reddy's remaining 3.19% stake influence future corporate decisions once the three-year KMP restriction period expires?

1 Year Returns:+71.85%